CME and CFTC Clash Over On-Chain Perpetual Futures

The rift between the CME Group and the US Commodity Futures Trading Commission (CFTC) has escalated into a full-blown battle, with the CME suing the regulator over its decision to allow blockchain-based perpetual futures products. The CFTC had given the green light to Kalshi and Coinbase to list crypto perpetual futures, but the CME argues that these products are mislabeled and do not comply with existing laws. The CME claims that perpetual futures, which allow users to speculate on asset prices with leverage and no expiration date, are harmful to its traditional futures products and that the CFTC's sudden embrace of them did not consider the ramifications. The dispute has significant implications for the rapidly growing market, with non-US perpetual futures volume reportedly reaching $60 trillion in 2023. The CME's lawsuit argues that the CFTC is misapplying the law by allowing perpetual futures, which do not have an end date, to be treated as traditional futures contracts. The regulator's decision has been met with frustration from those who support the CFTC's reform agenda, with some viewing the CME's actions as an attempt to stifle innovation and maintain its dominance in the market. The CFTC's chairman, Mike Selig, has defended the regulator's decision, stating that the CME's actions are 'wholly inappropriate' and that the regulator is committed to undertaking a 'reasoned analysis' of the issues at stake. The dispute is likely to have far-reaching consequences for the US derivatives market and the development of on-chain perpetual futures products. The CME's influence over commodities and its successful lobbying efforts in Washington DC have given it significant sway over regulatory decisions, but the CFTC's determination to open up the market to new products and players has created a rift between the two entities. As the legal battle unfolds, the future of CFTC-driven perpetual futures remains uncertain, with the CME preparing its case and the regulator standing by its decision to allow these products to be listed. The outcome of this dispute will have significant implications for the development of the US derivatives market and the growth of on-chain perpetual futures products.